Journal article
Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
Abstract
OBJECTIVE: To present a Canadian economic evaluation on the cost-utility of ulipristal acetate (5 mg orally daily) compared to leuprolide acetate (3.75 mg intramuscular monthly) in the treatment of moderate-to-severe symptoms of uterine fibroids in women eligible for surgery.
METHODS: A probabilistic decision tree was constructed to model the pre-operative pharmacological management of uterine fibroids under the primary perspective of the …
Authors
Tsoi B; Blackhouse G; Ferrazzi S; Reade CJ; Chen I; Goeree R
Journal
ClinicoEconomics and Outcomes Research, Vol. 7, No. 0, pp. 213–225
Publisher
Taylor & Francis
Publication Date
April 17, 2015
DOI
10.2147/ceor.s78115
ISSN
1178-6981